These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 18779785

  • 1. Big pharma swallows biotech's pride.
    Huggett B.
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract] [Full Text] [Related]

  • 2. Biotech's wonder ride.
    Rynecki D.
    Fortune; 2000 Mar 06; 141(5):435-6. PubMed ID: 10788046
    [No Abstract] [Full Text] [Related]

  • 3. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D.
    Fortune; 2002 Apr 15; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract] [Full Text] [Related]

  • 4. Biotech's next big blowup?
    Stires D.
    Fortune; 2002 Mar 18; 145(6):154. PubMed ID: 11913033
    [No Abstract] [Full Text] [Related]

  • 5. Biotech's billion dollar breakthrough.
    Stipp D.
    Fortune; 2003 May 26; 147(10):96-8, 100, 103. PubMed ID: 12776500
    [No Abstract] [Full Text] [Related]

  • 6. Early-stage returns?
    Booth BL.
    Nat Biotechnol; 2006 Nov 26; 24(11):1335-40. PubMed ID: 17093473
    [Abstract] [Full Text] [Related]

  • 7. The biotechnology industry: What's next?
    Guertin PA.
    Biotechnol J; 2009 Aug 26; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract] [Full Text] [Related]

  • 8. Japanese firms broaden investment focus to early biotech.
    Louët S, Sipp D.
    Nat Biotechnol; 2004 Aug 26; 22(8):931-2. PubMed ID: 15286631
    [No Abstract] [Full Text] [Related]

  • 9. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E.
    Nat Biotechnol; 2006 Mar 26; 24(3):261-2. PubMed ID: 16525376
    [No Abstract] [Full Text] [Related]

  • 10. Divining the path to a successful European exit.
    Buch HK, Gustafsson AC, Drvota V, Sundberg CJ.
    Nat Biotechnol; 2011 Mar 26; 29(3):205-7. PubMed ID: 21510008
    [No Abstract] [Full Text] [Related]

  • 11. Bugs or drugs, tortoises or hares?
    Jacobs T.
    Nat Biotechnol; 2005 Mar 26; 23(3):293. PubMed ID: 15765079
    [No Abstract] [Full Text] [Related]

  • 12. The stampede to convertibles.
    Jacobs T.
    Nat Biotechnol; 2003 Aug 26; 21(8):855. PubMed ID: 12894195
    [No Abstract] [Full Text] [Related]

  • 13. Bioentrepreneurship around the world.
    Persidis A.
    Nat Biotechnol; 1998 May 26; 16 Suppl():3-4. PubMed ID: 9591247
    [No Abstract] [Full Text] [Related]

  • 14. Biotechs hold their own in shifting industry.
    Mitchell P.
    Nat Biotechnol; 2002 Nov 26; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract] [Full Text] [Related]

  • 15. Any diamonds in the diagnostic coal?
    Jacobs T.
    Nat Biotechnol; 2006 Aug 26; 24(8):930. PubMed ID: 16900133
    [No Abstract] [Full Text] [Related]

  • 16. Biotech slumps in Q1.
    Lawrence S.
    Nat Biotechnol; 2008 May 26; 26(5):486. PubMed ID: 18464769
    [No Abstract] [Full Text] [Related]

  • 17. Shutters come off IPO window.
    Hodgson J.
    Nat Biotechnol; 2002 Jan 26; 20(1):6. PubMed ID: 11753342
    [No Abstract] [Full Text] [Related]

  • 18. Biotech's balancing act.
    Smaglik P.
    Nature; 2003 May 15; 423(6937):363. PubMed ID: 12748656
    [No Abstract] [Full Text] [Related]

  • 19. Biotech's wellspring-a survey of the health of the private sector in 2015.
    Huggett B.
    Nat Biotechnol; 2016 Jun 09; 34(6):608-15. PubMed ID: 27281417
    [No Abstract] [Full Text] [Related]

  • 20. A rollercoaster ride.
    Jacobs T.
    Nat Biotechnol; 2006 Mar 09; 24(3):284. PubMed ID: 16525390
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.